FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008407604> ?p ?o ?g. }

• W2008407604 endingPage "575" @default.
• W2008407604 startingPage "561" @default.
• W2008407604 abstract "IL-12 has significant antitumor activity in mice that may be mediated by CD8(+) T cells. We show in this report that repeated subcutaneous injections of IL-12 in patients with cancer resulted in the selective expansion of a subset of peripheral blood CD8(+) T cells. This T cell subset expressed high levels of CD18 and upregulated IL-12 receptor expression after IL-12 treatment in vivo. In normal subjects, these CD3(+)CD8(+)CD18(bright) T cells expressed IL-12 and IL-2 receptors and adhesion/costimulatory molecules to a greater degree than other CD8(+) and CD4(+) T cells. They appeared morphologically as large granular lymphocytes, although they did not express NK cell markers such as CD56. In addition, CD8(+)CD18(bright) T cells were almost exclusively T cell receptor (TCR) alphabeta+, and exhibited a TCR Vbeta repertoire that was strikingly oligoclonal, whereas the Vbeta repertoire of CD18(dim) T cells was polyclonal. Although CD8+CD18(bright) T cells demonstrated little functional responsiveness to IL-12 or IL-2 alone in vitro, they responded to the combination of IL-12+IL-2 with strong IFN-gamma production and proliferation and enhanced non-MHC-restricted cytolytic activity. In contrast, CD18(dim) T cells were not activated by IL-12 or IL-2, alone or in combination. These findings demonstrate that CD8+CD18(bright) T cells are a unique population of peripheral blood lymphocytes with features of both memory and effector cells that are capable of TCR-independent activation through combined stimulation with IL-12+IL-2. As this activation results in IFN-gamma production and enhanced cytolytic activity, these T cells may play a role in innate as well as acquired immunity to tumors and infectious pathogens. Additional studies will be necessary to determine whether CD8+CD18(bright) T cells mediate the antitumor effect of IL-12 or IL-2 administered to cancer patients, and if so, whether maximal activation of these T cells with the combination of IL-12+IL-2 in vivo can augment the clinical effectiveness of these cytokines." @default.
• W2008407604 created "2016-06-24" @default.
• W2008407604 creator A5003947352 @default.
• W2008407604 creator A5007681901 @default.
• W2008407604 creator A5008718116 @default.
• W2008407604 creator A5017133643 @default.
• W2008407604 creator A5024067356 @default.
• W2008407604 creator A5034112194 @default.
• W2008407604 creator A5047880272 @default.
• W2008407604 creator A5071186904 @default.
• W2008407604 creator A5082359860 @default.
• W2008407604 date "1998-08-01" @default.
• W2008407604 modified "2023-10-16" @default.
• W2008407604 title "Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12." @default.
• W2008407604 cites W1537668131 @default.
• W2008407604 cites W1568059997 @default.
• W2008407604 cites W1584518580 @default.
• W2008407604 cites W1609474951 @default.
• W2008407604 cites W1821988420 @default.
• W2008407604 cites W1829938205 @default.
• W2008407604 cites W1838853754 @default.
• W2008407604 cites W1924633993 @default.
• W2008407604 cites W1932492060 @default.
• W2008407604 cites W1945740511 @default.
• W2008407604 cites W1984992840 @default.
• W2008407604 cites W1995529916 @default.
• W2008407604 cites W1996032364 @default.
• W2008407604 cites W1998295547 @default.
• W2008407604 cites W2006073656 @default.
• W2008407604 cites W2006178861 @default.
• W2008407604 cites W2006294653 @default.
• W2008407604 cites W2008583523 @default.
• W2008407604 cites W2013068560 @default.
• W2008407604 cites W2020785153 @default.
• W2008407604 cites W2025082986 @default.
• W2008407604 cites W2030982793 @default.
• W2008407604 cites W2038260086 @default.
• W2008407604 cites W2044325609 @default.
• W2008407604 cites W2049998759 @default.
• W2008407604 cites W2051705414 @default.
• W2008407604 cites W2063116616 @default.
• W2008407604 cites W2069929656 @default.
• W2008407604 cites W2071743575 @default.
• W2008407604 cites W2078198072 @default.
• W2008407604 cites W2082649398 @default.
• W2008407604 cites W2091217693 @default.
• W2008407604 cites W2095636772 @default.
• W2008407604 cites W2096810938 @default.
• W2008407604 cites W2100510996 @default.
• W2008407604 cites W2102156468 @default.
• W2008407604 cites W2107860814 @default.
• W2008407604 cites W2109506765 @default.
• W2008407604 cites W2125010485 @default.
• W2008407604 cites W2126302947 @default.
• W2008407604 cites W2130901389 @default.
• W2008407604 cites W2138773604 @default.
• W2008407604 cites W2151707711 @default.
• W2008407604 cites W2294608654 @default.
• W2008407604 doi "https://doi.org/10.1172/jci3861" @default.
• W2008407604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/508917" @default.
• W2008407604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9691093" @default.
• W2008407604 hasPublicationYear "1998" @default.
• W2008407604 type Work @default.
• W2008407604 sameAs 2008407604 @default.
• W2008407604 citedByCount "49" @default.
• W2008407604 countsByYear W20084076042013 @default.
• W2008407604 countsByYear W20084076042014 @default.
• W2008407604 countsByYear W20084076042023 @default.
• W2008407604 crossrefType "journal-article" @default.
• W2008407604 hasAuthorship W2008407604A5003947352 @default.
• W2008407604 hasAuthorship W2008407604A5007681901 @default.
• W2008407604 hasAuthorship W2008407604A5008718116 @default.
• W2008407604 hasAuthorship W2008407604A5017133643 @default.
• W2008407604 hasAuthorship W2008407604A5024067356 @default.
• W2008407604 hasAuthorship W2008407604A5034112194 @default.
• W2008407604 hasAuthorship W2008407604A5047880272 @default.
• W2008407604 hasAuthorship W2008407604A5071186904 @default.
• W2008407604 hasAuthorship W2008407604A5082359860 @default.
• W2008407604 hasBestOaLocation W20084076041 @default.
• W2008407604 hasConcept C129374314 @default.
• W2008407604 hasConcept C147483822 @default.
• W2008407604 hasConcept C153911025 @default.
• W2008407604 hasConcept C154317977 @default.
• W2008407604 hasConcept C167672396 @default.
• W2008407604 hasConcept C202751555 @default.
• W2008407604 hasConcept C203014093 @default.
• W2008407604 hasConcept C2776090121 @default.
• W2008407604 hasConcept C2777371288 @default.
• W2008407604 hasConcept C2778690821 @default.
• W2008407604 hasConcept C55493867 @default.
• W2008407604 hasConcept C79484868 @default.
• W2008407604 hasConcept C86803240 @default.
• W2008407604 hasConcept C8891405 @default.
• W2008407604 hasConcept C95444343 @default.
• W2008407604 hasConceptScore W2008407604C129374314 @default.
• W2008407604 hasConceptScore W2008407604C147483822 @default.
• W2008407604 hasConceptScore W2008407604C153911025 @default.
• W2008407604 hasConceptScore W2008407604C154317977 @default.

• next